4.3 Article

Investigation of parameters influencing incorporation, retention and cellular cytotoxicity in liposomal formulations of poorly soluble camptothecin

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Liposomal formulations of poorly soluble camptothecin: drug retention and biodistribution

Goril Eide Flaten et al.

JOURNAL OF LIPOSOME RESEARCH (2013)

Review Pharmacology & Pharmacy

Challenges in Development of Targeted Liposomal Therapeutics

Rupa R. Sawant et al.

AAPS JOURNAL (2012)

Review Pharmacology & Pharmacy

Tumor delivery of macromolecular drugs based on the EPR effect

Vladimir Torchilin

ADVANCED DRUG DELIVERY REVIEWS (2011)

Review Pharmacology & Pharmacy

Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects

Kazuo Maruyama

ADVANCED DRUG DELIVERY REVIEWS (2011)

Review Pharmacology & Pharmacy

Cationic nanoparticles for cancer therapy

Erem Bilensoy

EXPERT OPINION ON DRUG DELIVERY (2010)

Article Pharmacology & Pharmacy

Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agent

M. Habib Ali et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)

Review Medicine, Research & Experimental

Cancer Therapies Utilizing the Camptothecins: A Review of the in Vivo Literature

Vincent J. Venditto et al.

MOLECULAR PHARMACEUTICS (2010)

Article Pharmacology & Pharmacy

Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery

Yasemin Cirpanli et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)

Article Pharmacology & Pharmacy

Artificial lipids stabilized camptothecin incorporated in liposomes

Yoshie Maitani et al.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)

Review Nanoscience & Nanotechnology

PEGylation of nanocarrier drug delivery systems: State of the art

Melissa D. Howard et al.

JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2008)

Article Chemistry, Multidisciplinary

In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin

Masato Watanabe et al.

JOURNAL OF CONTROLLED RELEASE (2008)

Article Chemistry, Medicinal

Physicochemical characterization and membrane binding properties of camptothecin

Bilge Selvi et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2008)

Review Oncology

Topoisomerase I inhibitors: camptothecins and beyond

Yves Pommier

NATURE REVIEWS CANCER (2006)

Review Biochemistry & Molecular Biology

Review Camptothecin: Current Perspectives

Qing-Yong Li et al.

CURRENT MEDICINAL CHEMISTRY (2006)

Article Pharmacology & Pharmacy

In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes

HD Han et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)

Article Pharmacology & Pharmacy

Development and characterization of a novel liposome-based formulation of SN-38

JA Zhang et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)

Article Pharmacology & Pharmacy

Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability

AR Mohammed et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)

Review Chemistry, Multidisciplinary

Camptothecin delivery methods

A Hatefi et al.

PHARMACEUTICAL RESEARCH (2002)

Article Chemistry, Physical

Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol

GN Devaraj et al.

JOURNAL OF COLLOID AND INTERFACE SCIENCE (2002)

Review Pharmacology & Pharmacy

Camptothecins - A review of their chemotherapeutic potential

H Ulukan et al.

DRUGS (2002)